A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines

INTRODUCTION: Inhibiting the enzyme Fatty Acid Synthase (FASN) leads to apoptosis of breast carcinoma cells, and this is linked to human epidermal growth factor receptor 2 (HER2) signaling pathways in models of simultaneous expression of FASN and HER2. METHODS: In a xenograft model of breast carcino...

Descripción completa

Detalles Bibliográficos
Autores principales: Puig, Teresa, Aguilar, Helena, Cufí, Sílvia, Oliveras, Glòria, Turrado, Carlos, Ortega-Gutiérrez, Sílvia, Benhamú, Bellinda, López-Rodríguez, María Luz, Urruticoechea, Ander, Colomer, Ramon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326573/
https://www.ncbi.nlm.nih.gov/pubmed/22177475
http://dx.doi.org/10.1186/bcr3077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326573/
https://www.ncbi.nlm.nih.gov/pubmed/22177475
http://dx.doi.org/10.1186/bcr3077

Ejemplares similares